| Literature DB >> 30456961 |
Maryam Kohansal1, Ali Ghanbari Asad.
Abstract
Shiga toxin-producing Escherichia coli (STEC) O157 and non-O157 are food-borne pathogens and contaminants of foods of animal origin. This study was conducted to investigate the presence of virulence and integrase genes in STEC isolates from diarrhoeic calves in Fars Province, Iran. Five hundred and forty diarrheic neonatal calves were randomly selected for sampling. Rectal swabs were collected and cultured for isolation and identification of E. coli following standard methods. The isolates were analysed for the presence of class 1 integrons and bacterial virulence factors using polymerase chain reaction (PCR). Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion method. Out of 540 diarrhoeic faecal samples, 312 (57.7%) harboured E. coli and 71 (22.7%) of them were identified as STEC: 41(69.5%) carried the stx2 gene, 21 (35.6%) carried the stx1 gene and 3 (5%) carried both. Twenty-six (44%) of the isolates showed the eaegene. Among the STEC isolates examined for susceptibility to eight antimicrobial agents, erythromycin and penicillin (96.8%) resistance were most commonly observed, followed by resistances to ampicillin (71.8%), tetracycline (62.5%) and trimethoprim/sulfamethoxazole (39%). Integrons were detected by PCR in 36% of the STEC tested isolates, 57 (89%) of which showed resistance to at least three antimicrobial agents. Our findings should raise awareness about antibiotic resistance in diarrhoeic calves in Fars Province, Iran. Class 1 integrons facilitate the emergence and dissemination of multidrug-resistance (MDR) among STEC strains recovered from food animals.Entities:
Keywords: integron; shiga toxin-producing escherichia col; virulence factors
Mesh:
Substances:
Year: 2018 PMID: 30456961 PMCID: PMC6244070 DOI: 10.4102/ojvr.v85i1.1621
Source DB: PubMed Journal: Onderstepoort J Vet Res ISSN: 0030-2465 Impact factor: 1.792
Primers and polymerase chain reaction conditions used in this study.
| Gene | Primer sequence | Size of product (bp) | PCR programme | PCR volume (25 | Reference |
|---|---|---|---|---|---|
| F: CTT CGG TAT CCT ATT CCC GG | 484 | 25 cycles of 30 s at 94 °C | 2.5 | Tahamtan et al. ( | |
| F: CCA TGA CAA CGG ACA GCA GTT | 779 | 25 cycles of 30 s at 94 °C | 2.5 | Tahamtan et al. ( | |
| F: AAG CGA CTG AGG TCA CT | 384 | 25 cycles of 30 s at 94 °C | 2.5 | Vasconcellos et al. ( | |
| F: TGCGGGTYAARGATBTKGATTT* | 491 | 30 s at 94 °C, 35 s at 57 °C | 2.5 | Tahamtan et al. ( |
Note: B = C or G or T; K = G or T; R = A or G; Y = C or T*.
PCR, polymerase chain reaction; DNA, deoxyribonucleic acid; Taq, thermus aquaticus; stx, isolates carrying stx1 and/or stx2 genes; eae, isolates carrying eae gene; pb, base pair; IntI, encoded integrases.
FIGURE 1Agarose gels electerophoresis of Shiga toxin-producing Escherichia coli isolates. (a) Polymerase chain reaction amplification of the stx1 (551 bp) and stx2 (118 bp) genes. Lanes 1–3, stx1; lanes 1–3 and 5, stx2 and (b) polymerase chain reaction amplification of the eae gene (840 bp) (lanes 1–4, 6 and 7). Lane M, 100 bp molecular size markers; Lanes C- and C+, negative and positive control.
FIGURE 2Frequency of occurrence of tested virulence genes in 71 STEC strains.
Distribution of virulence genes in Shiga toxin-producing Escherichia coli strains.
| Pathotype | Serogroup | Positive sample | Number of isolates carrying specific genes | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No. | % | ||||||||||||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | ||||
| STEC | Non-O157 | 59 | 100.0 | 21 | 36 | 41 | 70 | 26 | 44.0 | 3 | 5.0 | 10 | 16.9 | 13 | 22.0 | 3 | 5.0 |
| O157 | 12 | - | 12 | - | 12 | - | 12 | - | 0 | - | 0 | - | 0 | - | 12 | - | |
| Total STEC | 71 | 100.0 | 33 | 46 | 53 | 75 | 38 | 54 | 3 | 4.2 | 10 | 14.0 | 13 | 18.3 | 15 | 21.1 | |
| Non-STEC | 241 | - | - | - | - | - | 63 | - | - | - | - | - | - | - | - | - | |
| Total | 312 | 100.0 | 33 | 11 | 53 | 17.0 | 101 | 32 | 3 | 0.9 | 10 | 3.2 | 13 | 4.1 | 15 | 4.8 | |
Overall: STEC, 71 (22.7%); Non-STEC, 241 (77.3%).
Overall: Non-O157, 52 (16.6%); O157, 12 (3.8%).
STEC, Shiga toxin-producing Escherichia coli; No., number; stx, isolates carrying stx1 and/or stx2 genes; eae, isolates carrying eae gene.
Note: The eae gene produces a 94-kDa outer membrane protein called intimin.
Antibiotic resistance pattern in Shiga toxin–producing Escherichia coli strains.
| STEC - Serogroup | No. positive | AM10 | C30 | CFM5 | E25 | ENR10 | P10 | SXT30 | TET30 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample | % | Sample | % | Sample | % | Sample | % | Sample | % | Sample | % | Sample | % | Sample | % | Sample | % | |
| Non-O157 | 52 | 100.0 | 38 | 73.0 | 21 | 40.0 | 13 | 25.0 | 51 | 98.0 | 11 | 21.1 | 51 | 98.0 | 52 | 100.0 | 34 | 65.3 |
| O157 | 12 | 18.7 | 10 | 83.0 | 0 | 3 | 25.0 | 8 | 66.6 | 0 | - | 11 | 91.6 | 0 | 8 | 66.6 | ||
| Total STEC | 64 | 100.0 | 48 | 75.0 | 21 | 32.8 | 16 | 25.0 | 59 | 92.1 | 11 | 17.1 | 62 | 96.8 | 25 | 39.0 | 42 | 65.6 |
AM10, ampicillin (10 µg/disk); TET30, tetracycline (30 µg/disk); E25, erythromycin (25 µg/disk); ENR10, enrofloxacin (10 µg/disk); SXT30, trimethoprim/sulfamethoxazole (30 µg/disk); C30, chloramphenicol (30 µg/disk); P10, penicillin (10 µg/disk); CFM5, cefixime (5 µg/disk); STEC, Shiga toxin-producing Escherichia coli; No., number.
FIGURE 3Antimicrobial susceptibility patterns in 71 Shiga toxin-producing Escherichia coli strains.
FIGURE 4Polymerase chain reaction amplicons of Shiga toxin-producing Escherichia coli integrons. Polymerase chain reaction amplification of the class 1 integron, integrase. bp, base pair; int1, integrase gene.
Overview of the integron-positive Shiga toxin–producing Escherichia coli strains.
| Strain | Serogroup | Virulence profile | Integron | Antibiotic resistance profile | MDR | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AM | C | CFM | E | ENR | P | SXT | TET | |||||
| PNU1 | Non-157 | 1 | + | R | S | S | R | S | R | R | R | + |
| PNU2 | Non-157 | 2 | + | S | S | S | R | S | R | R | R | + |
| PNU3 | Non-157 | 2 | + | R | R | S | R | R | S | R | R | + |
| PNU4 | Non-157 | 2 | + | R | R | S | R | R | R | R | R | + |
| PNU5 | Non-157 | 2 | + | R | S | S | R | S | R | S | R | + |
| PNU7 | Non-157 | 1 | + | R | S | R | R | S | R | S | R | + |
| PNU10 | Non-157 | 1 | + | R | S | R | R | S | R | S | R | + |
| PNU20 | O157 | 1, 2 | + | R | S | R | R | S | R | S | R | + |
| PNU21 | O157 | 1, 2 | + | R | S | R | R | S | R | S | R | + |
| PNU24 | O157 | 1, 2 | + | R | S | S | R | S | R | S | R | + |
| PNU26 | O157 | 1, 2 | + | S | S | S | R | S | R | S | S | - |
| PNU30 | Non-157 | 2 | + | R | R | S | R | R | R | R | R | + |
| PNU31 | Non-157 | 2 | + | R | R | S | R | R | R | R | R | + |
| PNU33 | Non-157 | 1 | + | R | R | S | R | R | R | R | R | + |
| PNU34 | Non-157 | 2 | + | S | R | S | R | S | R | R | R | + |
| PNU35 | Non-157 | 2 | + | R | S | R | R | S | R | S | R | + |
| PNU39 | Non-157 | 2 | + | S | R | S | R | S | R | R | R | + |
| PNU40 | Non-157 | 1 | + | R | S | S | R | R | R | R | R | + |
| PNU50 | Non-157 | 1 | + | R | R | S | R | R | R | R | R | + |
| PNU51 | Non-157 | 2 | + | R | R | R | R | S | R | R | R | + |
| PNU58 | Non-157 | 2 | + | R | S | S | R | S | R | R | R | + |
| PNU61 | Non-157 | 2 | + | R | R | S | R | S | R | R | R | + |
| PNU62 | Non-157 | 2 | + | R | S | S | R | S | R | R | R | + |
Note: Antibiotic resistance profile was determined for eight antibiotics: ampicillin (AM), tetracycline (TET), erythromycin (E), enrofloxacin (ENR), trimethoprim/sulfamethoxazole (SXT), chloramphenicol (C), penicillin (P) and cefixime (CFM).
stx, isolates carrying stx1 and/or stx2 genes; MDR, multidrug-resistant isolates; S, antibiotic-susceptible isolates; R, antibiotic-resistant isolates.
+, positive for int gene or MDR.
Comparison of the resistances between integron-positive and integron-negative strains was done using the p-values listed in the table.
| Antibiotic | Resistance | Resistance | Resistance of total isolates | Association with integron | |||
|---|---|---|---|---|---|---|---|
| No. | % | No. | % | No. | % | ||
| Ampicillin | 19 | 29.6 | 28 | 42.2 | 47 | 71.8 | 0.2523 |
| Erythromycin | 23 | 35.9 | 39 | 60.9 | 62 | 96.8 | 0.5322 |
| Penicillin | 22 | 34.3 | 40 | 62.5 | 62 | 96.8 | 1.0000 |
| Tetracycline | 21 | 32.8 | 20 | 29.6 | 41 | 62.5 | 0.0009 |
| Trimethoprim/sulfamethoxazole | 15 | 23.4 | 10 | 15.6 | 15 | 39.00 | 0.0032 |
| Cefixime | 7 | 10.9 | 9 | 14.1 | 16 | 25.00 | 0.6521 |
| Enrofloxacin | 7 | 10.9 | 4 | 6.2 | 11 | 17.1 | 0.0456 |
| Chloramphenicol | 10 | 15.6 | 11 | 17.1 | 21 | 32.8 | 0.2780 |
Note: p values of 0.05 were considered to be significant.
int-positive, integron-positive in PCR assay; int-negative, integron-negative in PCR assay.
int, integron; No., number.
, Correlation is significant at the 0.05 level.